Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Tanaka

Showing results (121-130 of 194) with videos related to

Pageof 20
Sort By:
Acta Medica Okayama|October 26, 2019
Acute Prevertebral Abscesses Caused by Bacterial-infected Traumatic Tooth FracturesKazuyuki Matsunaga, Makoto Takemaru, Keisuke Yamashiro, et al.
The British Journal of Dermatology|October 23, 2024
Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J)Norito Katoh, Akio Tanaka, Hidetoshi Takahashi, et al.
Journal of Oral Science|July 1, 2008
Keratocystic odontogenic tumor: a retrospective study of 183 casesPatricia González-Alva, Akio Tanaka, Yuka Oku, et al.
Acta Dermato-Venereologica|September 9, 2024
Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic DermatitisAkio Tanaka, Ken Igawa, Hidetoshi Takahashi, et al.
The Journal of Dermatology|March 20, 2016
Oral administration of β-carotene or lycopene prevents atopic dermatitis-like dermatitis in HR-1 miceMakiko Hiragun, Takaaki Hiragun, Ikumi Oseto, et al.
Dermatologic Therapy|April 20, 2022
Real-world efficacy of proactive maintenance treatment with delgocitinib ointment twice weekly in adult patients with atopic dermatitisMasataka Suehiro, Tomofumi Numata, Emi Murakami, et al.
International Journal of Molecular Sciences|August 12, 2023
Time Course of Priming Effect of TF Inducers on Synergistic TF Expression and Intra-Cellular Gap Formation of Human Vascular Endothelial Cells via the Extrinsic Coagulation CascadeDaiki Matsubara, Takuma Kunieda, Yuhki Yanase, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2020
Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptorYuhki Yanase, Yoshimi Matsuo, Shunsuke Takahagi, et al.
The Journal of Dermatology|February 24, 2021
Time course of disease severity from birth to 19 years old in patients with moderate to severe atopic dermatitis in adulthoodAkio Tanaka, Satoshi Morioke, Yukihiro Ohya, et al.
The Journal of Dermatology|August 5, 2020
Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-α, interleukin (IL)-33 or IL-1βAkiko Kamegashira, Yuhki Yanase, Shunsuke Takahagi, et al.
Pageof 20

Showing results (121-130 of 194) with videos related to

Sort By:
Pageof 20
Acta Medica Okayama|October 26, 2019
Acute Prevertebral Abscesses Caused by Bacterial-infected Traumatic Tooth FracturesKazuyuki Matsunaga, Makoto Takemaru, Keisuke Yamashiro, et al.
The British Journal of Dermatology|October 23, 2024
Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J)Norito Katoh, Akio Tanaka, Hidetoshi Takahashi, et al.
Journal of Oral Science|July 1, 2008
Keratocystic odontogenic tumor: a retrospective study of 183 casesPatricia González-Alva, Akio Tanaka, Yuka Oku, et al.
Acta Dermato-Venereologica|September 9, 2024
Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic DermatitisAkio Tanaka, Ken Igawa, Hidetoshi Takahashi, et al.
The Journal of Dermatology|March 20, 2016
Oral administration of β-carotene or lycopene prevents atopic dermatitis-like dermatitis in HR-1 miceMakiko Hiragun, Takaaki Hiragun, Ikumi Oseto, et al.
Dermatologic Therapy|April 20, 2022
Real-world efficacy of proactive maintenance treatment with delgocitinib ointment twice weekly in adult patients with atopic dermatitisMasataka Suehiro, Tomofumi Numata, Emi Murakami, et al.
International Journal of Molecular Sciences|August 12, 2023
Time Course of Priming Effect of TF Inducers on Synergistic TF Expression and Intra-Cellular Gap Formation of Human Vascular Endothelial Cells via the Extrinsic Coagulation CascadeDaiki Matsubara, Takuma Kunieda, Yuhki Yanase, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2020
Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptorYuhki Yanase, Yoshimi Matsuo, Shunsuke Takahagi, et al.
The Journal of Dermatology|February 24, 2021
Time course of disease severity from birth to 19 years old in patients with moderate to severe atopic dermatitis in adulthoodAkio Tanaka, Satoshi Morioke, Yukihiro Ohya, et al.
The Journal of Dermatology|August 5, 2020
Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-α, interleukin (IL)-33 or IL-1βAkiko Kamegashira, Yuhki Yanase, Shunsuke Takahagi, et al.
Pageof 20